pmc.ncbi.nlm.nih.gov/articles/PMC...
pmc.ncbi.nlm.nih.gov/articles/PMC...
https://www.biorxiv.org/content/10.1101/2025.04.30.651587v1
https://www.biorxiv.org/content/10.1101/2025.04.30.651587v1
https://www.biorxiv.org/content/10.1101/2025.03.04.641483v1
https://www.biorxiv.org/content/10.1101/2025.03.04.641483v1
"Ian Folkert and and colleagues show that iron-rich tumor-associated macrophages shape anti-tumor immunity — pointing to a promising new target to boost immunotherapy responses." - Marc Guasch, PhD student
rupress.org/jem/article/...
"Ian Folkert and and colleagues show that iron-rich tumor-associated macrophages shape anti-tumor immunity — pointing to a promising new target to boost immunotherapy responses." - Marc Guasch, PhD student
rupress.org/jem/article/...
https://littlebunker.com/2025/10/29/research_papers-joint-disruption-of-ret-and-ed-ae7bf921/
https://littlebunker.com/2025/10/29/research_papers-joint-disruption-of-ret-and-ed-ae7bf921/
If this happens, the N-terminal ext. may get tagged with spurious pathogenic mutations (as in PUS1, TMCO1 and EDNRB) that will be hard to correct.
If this happens, the N-terminal ext. may get tagged with spurious pathogenic mutations (as in PUS1, TMCO1 and EDNRB) that will be hard to correct.
Here are two annotated signal-peptide displacing examples that are already annotated with imaginary pathogenic variations (TMCO1 and EDNRB).
Here are two annotated signal-peptide displacing examples that are already annotated with imaginary pathogenic variations (TMCO1 and EDNRB).